SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.76+1.6%3:35 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WillDearborn who wrote (947)4/3/1998 2:22:00 PM
From: Perry  Read Replies (2) of 9523
 
<<There is room for more than one player in this market.>>

I think you are right about other ED drugs having a place in this market. However, I personally feel that investing in a drug powerhouse like Pfizer is a much better bet than a smaller company with a drug only in phase II trials. From what I have read about these trials,the numbers are only in the low hundreds whereas Viagra was tested in thousands of ED patients. I wouldn't be surprised to see reports of side effects with Topiglan once a larger study is conducted.

Nevertheless good luck to you.
Perry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext